Acute respiratory tract infections, including acute upper respiratory tract infections and acute bronchitis Infections and Infestations
Conditions
Interventions
Current interventions as of 12/02/2020:
All recruited township hospitals will be stratified by county and be randomized into the intervention or control group in an overall 1:1 ratio with a 9:8 ratio
Sponsors
First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
0 Years to 75 Years
Inclusion criteria
Inclusion criteria: Healthcare professionals: 1. Physicians, pharmacists, radiologists and directors in enrolled township hospitals in two selected counties in Shaoguan City, Guangdong Province who agree to participate in the study Patient/caregivers: 1. Patients aged 0-75 years diagnosed with acute RTIs and/or their caregivers
Exclusion criteria
Exclusion criteria: Township hospitals: 1. Township hospitals that have participated in the pilot study Patients: 1. Non-acute RTI 2. Pneumonia 3. Chronic conditions including asthma, COPD, non-infective or non-acute disorders 4. Immunological deficiencies 5. Tuberculosis 6. Any form of cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of prescriptions for acute RTIs that contain any antibiotic. All primary and secondary outcomes will be collected from electronic medical records at baseline (12 months before intervention), intervention period (12 months) and long-term follow-up period (24 months after intervention). | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 12/02/2020: 1. Broad-spectrum antibiotic prescription rate 2. Fluoroquinolones prescription rate 3. Prescription rate for multiple antibiotics 4. Intravenous injection antibiotic prescription rate 5. The proportion of prescriptions containing any antibiotics in the Access group of the WHO’s 2019 Essential Medicine List classification 6. The proportion of prescriptions containing any Traditional Chinese Medicines 7. The proportion of prescriptions containing any glucocorticoids 8. The average cost of a prescription 9. The average cost of a consultation Previous secondary outcome measures: 1. Broad spectrum antibiotic prescription rate 2. Prescription rate for broad spectrum antibiotics excluding amoxicillin-clavulanic acid 3. Prescription rate for multiple antibiotics 4. Intravenous injection antibiotic prescription rate 5. Prescription rate for alternative medicines 6. Average cost of a prescription All primary and secondary outcomes will be collected from electronic medical records at baseline (12 months before intervention), intervention period (12 months) and long-term follow-up period (24 months after intervention). | — |
Countries
China
Contacts
Public ContactChao Zhuo
Outcome results
None listed